Authors: LEIDERMAN E ZYLBERMAN I ZUKIN SR COOPER TB JAVITT DC

Citation: E. Leiderman et al., PRELIMINARY INVESTIGATION OF HIGH-DOSE ORAL GLYCINE ON SERUM LEVELS AND NEGATIVE SYMPTOMS IN SCHIZOPHRENIA - AN OPEN-LABEL TRIAL, Biological psychiatry, 39(3), 1996, pp. 213-215

Authors: ZYLBERMAN I JAVITT DC ZUKIN SR

Citation: I. Zylberman et al., NMDA RECEPTOR AUGMENTATION THERAPY IN SCHIZOPHRENIA, Schizophrenia research, 15(1-2), 1995, pp. 171-171

Authors: JAVITT DC FRUSCIANTE MJ ZUKIN SR

Citation: Dc. Javitt et al., ACTIVATION-RELATED AND ACTIVATION-INDEPENDENT EFFECTS OF POLYAMINES ON PHENCYCLIDINE RECEPTOR-BINDING WITHIN THE N-METHYL-D-ASPARTATE RECEPTOR COMPLEX, The Journal of pharmacology and experimental therapeutics, 270(2), 1994, pp. 604-613

Authors: JAVITT DC ZYLBERMAN I ZUKIN SR HERESCOLEVY U LINDENMAYER JP

Citation: Dc. Javitt et al., AMELIORATION OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA BY GLYCINE, The American journal of psychiatry, 151(8), 1994, pp. 1234-1236

Authors: ZUKIN SR JAVITT DC ZYLBERMAN I HERESCOLEVY U

Citation: Sr. Zukin et al., GLUTAMATERGIC DYSFUNCTION IN PSYCHIATRIC-DISORDERS, Neuropsychopharmacology, 9(2), 1993, pp. 190000038-190000039

Authors: ZUKIN SR NUSSENZVEIG IZ JAVITT DC HERESCOLEVY U SIRCAR R LINDENMAYER JP

Citation: Sr. Zukin et al., ARE NMDA RECEPTORS INVOLVED IN SCHIZOPHRENIA - CANDIDATE MECHANISMS AND EFFECT OF HIGH-DOSE ORAL GLYCINE, Journal of neurochemistry, 61, 1993, pp. 190000051-190000051